Kura Oncology, Inc. (KURA)
NASDAQ: KURA · IEX Real-Time Price · USD
20.95
-0.55 (-2.56%)
At close: Jul 19, 2024, 4:00 PM
20.87
-0.08 (-0.38%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $1.60 billion as of July 22, 2024. Its market cap has increased by 130.43% in one year.
Market Cap
1.60B
Enterprise Value
1.09B
1-Year Change
130.43%
Ranking
Category
Stock Price
$20.95
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $1.60B, an increase of 1,303.68%. That is a compound annual growth rate of 35.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.60B | 49.44% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galapagos NV | 1.72B |
| Soleno Therapeutics | 1.71B |
| NewAmsterdam Pharma Company | 1.70B |
| Evotec SE | 1.67B |
| Supernus Pharmaceuticals | 1.66B |
| Avadel Pharmaceuticals | 1.56B |
| MannKind | 1.55B |
| Schrödinger | 1.55B |